One of the most popular questions people ask when it comes to CBD aside from its dosage and legality, is its safety and efficacy when taken alongside prescription medications.
Right off the bat, we want to clearly express that the best way to answer this question is to ask your doctor as they know your medical history and other important factors that should be taken into account when answering this question.
A Little Recap
Cannabidiol (CBD), is a molecule found in the cannabis plant that is extracted using varying methods and then combined with a carrier oil with altering concentrations and potencies to create a final product such as CBD oils, syrups, gummies, and more.
CBD products have become a common staple in many households due to its natural ability to support certain health conditions. Medically reviewed studies demonstrate that the most common mechanisms of CBD include that of inflammation, pain, sleep, and anxiety management.
CBD vs. THC
While CBD is not FDA approved, the Farm Bill passed in 2018 states that CBD is legal as long as its THC content is no more than .3% THC. THC and CBD are very different even though they come from the same cannabis plant.
THC is most commonly used recreationally to induce a euphoric effect through the well-known high whereas CBD is used for potential health benefits and is not psychoactive.
The most common side effects of CBD are often mild ranging from sleepiness to dry mouth while most people don’t experience any negative side effects at all. In rare cases though, CBD may cause liver toxicity.



![CBD and Drug Interactions: Do's & Don'ts | ReThink [#1] Best CBD Products Made in USA | THC Free | CBD ReThink](https://cbdrethink.com/wp-content/uploads/2021/10/cbd-drug-interactions-3.jpg)
2 Comments. Leave new
A list of medications that have interactions or a link to the study that was mentioned would be helpful.
Good Morning Nancy!
We agree with you and our working on adding the links to the blog.
For now, I’ll add the links in this comment for your and other’s reference:
https://sites.psu.edu/cannabinoid/files/2020/06/NTI-Meds-to-be-Closely-Monitored-when-Co-Administered-with-Cannabinoids_2020_04_25.pdf
https://news.psu.edu/story/627290/2020/08/03/research/cannabinoids-may-affect-activity-other-pharmaceuticals